| Product ID |
CAS Number |
Product Name |
Quantity |
| A1-0191 |
16801-62-0 |
4-N-Cbz-Aminocyclohexanol |
|
| A1-0193 |
320590-29-2 |
3-N-Cbz-Aminocyclohexanone |
|
| A1-0197 |
31236-61-0 |
2-N-Cbz-Aminocyclohexanone |
|
| A1-0199 |
92645-06-2 |
2-N-Cbz-Aminocyclohexanol |
|
| A1-0208 |
120278-07-1 |
1-N-CBZ-4-Aminopiperidine |
|
| AS-0215 |
6/9/5720 |
2-Methoxyphenylboronic acid |
|
| AS-0790 |
204841-19-0 |
3-Acetylphenylboronic acid |
|
| AS-2594 |
3107-33-3 |
3-(Trifluoromethyl)phenylhydrazine hydrochloride |
|
| AS-2604 |
55912-20-4 |
4-CHLORO-3-NITROBENZYL ALCOHOL |
|
| AS-2691 |
185690-41-9 |
4,4',4''-Tris[2-naphthyl(phenyl)amino]triphenylamine |
|
| AS-2693 |
3001-15-8 |
4,4'-Diiodobiphenyl |
|
| AS-2695 |
92-86-4 |
4,4'-Dibromobiphenyl |
|
| AS-2845 |
64882-65-1 |
2,3-DIHYDRO-3-OXO-4-PYRIDAZINECARBONITRILE |
|
| AS-3609 |
533-31-3 |
Sesamol |
|
| AS-3823 |
118-83-2 |
5-Chloro-2-nitrobenzotrifluoride |
|
| AS-4333 |
18063-03-1 |
2,6-Difluorobenzamide |
|
| AS-4747 |
34946-82-2 |
COPPER(II) TRIFLUOROMETHANESULFONATE |
|
| AS-5494 |
2743-40-0 |
Ethyl L-leucinate hydrochloride |
|
| AS-5506 |
4727-72-4 |
1-Benzyl-4-hydroxypiperidine |
|
| AS-5531 |
123-30-8 |
4-Aminophenol |
|
| AS-5951 |
85977-52-2 |
(S)-(-)-1,2,3,4-Tetrahedro-naphthoic acid |
|
| AS-5961 |
83792-47-6 |
N-Fmoc-N'-tosyl-L-arginine |
|
| AS-7711 |
57892-73-6 |
Imidazo(1,2-a)pyrimidine-2-aceticacid |
|
| AS-7720 |
4660-80-4 |
ETHYL 2,3-EPOXYPROPANOATE |
|
| AS-8078 |
101-02-0 |
Triphenyl phosphite |
|
| JR6-L2101 |
951174-50-8 |
[1,1'-Biphenyl]-4-propanoic acid, ß-amino-, (ßS)- |
|
| JR6-L2292 |
171764-07-1 |
Butanamide, 2-amino-3,3-dimethyl-N-2-pyridinyl-, (2S)- |
|
| JR6-L2294 |
1185897-80-6 |
Butanamide, 2-amino-3,3-dimethyl-N-(3-pyridinylmethyl)-, (2S)- |
|
| JR6-L2295 |
260265-09-6 |
Butanamide, 2-amino-3,3-dimethyl-N-(2-pyridinylmethyl)-, (2S)- |
|
| JR6-L2298 |
936247-64-2 |
Butanamide, 2-amino-N-(4-methoxyphenyl)-3,3-dimethyl-, (2S)- |
|
| JR6-L2308 |
171764-16-2 |
Butanamide, 2-amino-N-(2-methoxyphenyl)-3,3-dimethyl-, (S)- (9CI) |
|
| JR6-L3361 |
957230-58-9 |
[1,1'-Binaphthalene]-2,2'-diol, 3-ethyl-, (1S)- |
|
| JR6-L3507 |
340825-63-0 |
Oxirane, 2-[2-[4-(phenylmethoxy)phenyl]ethyl]-, (2R)- |
|
| JR6-L3508 |
1233884-98-4 |
(R)-2-(3,4-dimethoxyphenethyl)oxirane |
|
| JR6-L3509 |
1263776-82-4 |
Oxirane, 2-(9H-fluoren-9-ylmethyl)-, (2R)- |
|
| JR6-L3611 |
1450736-44-3 |
(3-((4-((4-(3-chlorophenyl)-5-(3,4-dimethylphenyl)pentyl)thio)benzyl)amino)propyl)phosphonic acid |
|
| JR6-L3615 |
95611-10-2 |
1H-Thieno[3,4-d]imidazole-4-pentanamide, hexahydro-N-(2-hydroxyethyl)-2-oxo-, (3aS,4S,6aR)- |
|
| JR6-L3617 |
917015-56-6 |
Butanoic acid, 2-[[5-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]- |
|
| JR6-L3628 |
663171-32-2 |
1H-Thieno[3,4-d]imidazole-4-pentanamide, N-(14-amino-3,6,9,12-tetraoxatetradec-1-yl)hexahydro-2-oxo-, (3aS,4S,6aR)- |
|
| JR6-L3631 |
1365655-89-5 |
Propanoic acid, 3-[2-[2-[[5-[(3aR,4R,6aS)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxopentyl]amino]ethoxy]ethoxy]-, rel- |
|
| JR6-L4867 |
74205-10-0 |
Cyclobutanecarbonitrile, 1-(2-methoxyphenyl)- |
|
| JR6-L4871 |
29786-44-5 |
Cyclobutanecarbonitrile, 1-[4-(trifluoromethyl)phenyl]- |
|
| JR6-L4873 |
1215104-00-9 |
Cyclobutanecarbonitrile, 1-(3-nitrophenyl)- |
|
| JR6-L4876 |
749929-04-2 |
Cyclobutanecarbonitrile, 1-(4-bromo-2-fluorophenyl)- |
|
| JR6-L4879 |
29786-43-4 |
Cyclobutanecarbonitrile, 1-[3-(trifluoromethyl)phenyl]- |
|
| JR6-L4881 |
339094-25-6 |
Cyclobutanecarbonitrile, 1-(3,5-dimethoxyphenyl)- |
|
| JR6-L4883 |
1314791-45-1 |
Cyclobutanecarbonitrile, 1-[4-(methylsulfonyl)phenyl]- |
|
| JR6-L6030 |
477727-17-6 |
[1,1'-Biphenyl]-4,4'-diol, 3-[2-amino-6-[([1,1'-biphenyl]-2-ylmethyl)amino]-4-pyrimidinyl]- |
|
| JR6-L6035 |
945976-33-0 |
L-Phenylalanine, 4-[2-amino-6-[[(1R)-1-(2-naphthalenyl)ethyl]amino]-4-pyrimidinyl]- |
|
| JR6-L6042 |
945976-35-2 |
L-Phenylalanine, 4-[2-amino-6-[methyl[(1R)-1-(2-naphthalenyl)ethyl]amino]-4-pyrimidinyl]- |
|
| JR6-L6054 |
1227910-99-7 |
2,4-Pyrimidinediamine, 6-(3-amino-1H-indazol-6-yl)-N4-(2,3-dihydro-1H-inden-1-yl)- |
|
| JR6-L6180 |
28558-58-9 |
Benzenesulfonamide, 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(3,4-dimethyl-5-isoxazolyl)- |
|
| JR6-L7920 |
1344451-84-8 |
2H-Indol-2-one, 3-amino-1,3-dihydro-3-(4-methoxyphenyl)-, (3R)- |
|
| JR6-L7922 |
1344411-52-4 |
2H-Indol-2-one, 3-amino-1,3-dihydro-3,6-dimethyl-, (3R)- |
|
| JR6-L7928 |
1344627-77-5 |
2H-Indol-2-one, 3-amino-6-bromo-1,3-dihydro-3-methyl-, (3S)- |
|
| JR6-L7936 |
1344414-63-6 |
1H-Indole-3-carboxylic acid, 3-amino-2,3-dihydro-2-oxo-, (3S)- |
|
| JR6-L7938 |
1344414-00-1 |
2H-Indol-2-one, 3-amino-7-chloro-1,3-dihydro-3-methyl-, (3S)- |
|
| JR8-N0260 |
68406-26-8 |
Ginsenoside Rb3 |
|
| JR8-N0264 |
39262-14-1 |
Compound CK |
|
| JR8-N0314 |
231-456-0 |
Usinic acid |
|
| JR8-N0316 |
139-85-5 |
protocatechuicaldehyde |
|
| JR8-N0318 |
51059-44-0 |
Wogonoside |
|
| JR8-N0328 |
71610-00-9 |
Cephalomannine |
|
| JR8-N0331 |
90332-66-4 |
7-xylosyltaxol |
|
| JR8-N0416 |
6817-41-0 |
Isoliensinine |
|
| JR8-N0575 |
61303-13-7 |
Isoacteoside |
|
| JR8-N0579 |
126054-77-1 |
atractyloside A |
|
| JR8-N0584 |
18642-23-4 |
psoralidin |
|
| JR8-N1136 |
16836-31-0 |
kaurane-16C17-diol |
|
|
|
|
|
|
|
|
|
|
|
|
|